Adipose Tissue Overexpression of Nicotinamide Phosphoribosyltransferase Prevents Metabolic Dysfunction in Obese Mice via Extracellular Vesicles
Diabetes · 2026
DOI: 10.2337/db25-0914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2026. Verfasst von Daniel Ferguson und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center for Human Nutrition, Division of Nutritional Science and Obesity Medicine, Department of Medicine, Washington University School of Medicine in…. Hauptthemen laut MEDLINE: Nicotinamide Phosphoribosyltransferase, Adipose Tissue, Obesity, Extracellular Vesicles. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: JSPS Kakenhi, Diabetes Research Center at Washington University in St. Louis, Hope Center Alafi Neuroimaging Lab at Washington University School of Medicine.
Abstract (Originalsprache)
Nicotinamide phosphoribosyltransferase (NAMPT) maintains the cellular NAD+ pool, and diminished adipocyte NAMPT activity has been implicated in aging- and obesity-related metabolic dysfunction. We generated adipocyte-specific NAMPT overexpressing (ANOV) mice and examined their metabolic phenotypes. Male ANOV mice were protected from high-fat diet–induced metabolic dysfunction, including the development of adipose tissue inflammation and glucose intolerance. In contrast, female ANOV mice were less protected from metabolic dysfunction, possibly due to higher endogenous expression of NAMPT in wild-type female mice. Livers of ANOV mice showed improved insulin signaling, increased NAD+ content, and reduced steatosis, suggesting that NAMPT regulates interorgan communication between adipocytes and hepatocytes. We show that adipose tissue–derived extracellular vesicles (EVs) isolated from ANOV mice enhanced insulin signaling in HepG2 cells and liver and improved glucose tolerance in mice. NAMPT overexpression altered EV cargo composition, including decreased ceramides and increased content of NAD+ and NAMPT. Treating HepG2 cells with an NAMPT inhibitor blunted the effects of ANOV-EV on insulin signaling, suggesting that transfer of NAMPT to recipient cells mediates at least some of the beneficial effects of ANOV-EV. Collectively, these data highlight a novel mechanism by which adipocyte NAMPT regulates systemic metabolic dysfunction via EVs. Article Highlights NAD+ is an essential cofactor for many metabolic reactions. Nicotinamide phosphoribosyltransferase (NAMPT) is an important enzyme in NAD+ biosynthesis, and diminished adipocyte NAD+ and NAMPT have been implicated in metabolic dysfunction. Mice with adipocyte NAMPT overexpression (ANOV) were protected from diet-induced metabolic dysfunction, including adipose tissue inflammation, glucose intolerance, and hepatic steatosis. Extracellular vesicles from ANOV mice improved glucose tolerance in obese mice. Compared with wild-type mice, adipose tissue extracellular vesicles from ANOV mice exhibited marked changes in lipid and metabolite cargoes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Human Nutrition, Division of Nutritional Science and Obesity Medicine, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO.
- Foundational Biomedical Sciences, Touro University California, Vallejo, CA.
- Department of Cell Biology and Physiology, Washington University School of Medicine in St. Louis, St. Louis, MO.
- The Genome Engineering and Stem Cell Center, McDonnell Genome Institute, Washington University School of Medicine in St. Louis, St. Louis, MO.
- Departments of Cell Biology and Physiology and Division of Endocrinology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, MO.
- Center for Mass Spectrometry and Metabolic Tracing, Department of Chemistry, Washington University, St Louis, MO.
ORCID-Profile: John P Thyfault, Brian N Finck, Sandip Mukherjee
Förderung
- JSPS Kakenhi
- Diabetes Research Center at Washington University in St. Louis
- Hope Center Alafi Neuroimaging Lab at Washington University School of Medicine
- Digestive Diseases Research Core Center, Washington University in St. Louis
- NCRR NIH HHS
- NIDDK NIH HHS
- NIH HHS
- NCI Cancer Center Support, Siteman Cancer Center
Zitieren
APA
Ferguson, D., Gadson, E. I., Markan, K. R., Yoshino, J., Palacios, H., Lin, M., Habibi, M., Tiash, S., Cui, X., Kouranova, E., Franczak, E., Guo, Q., Nguyen, T., Kealing, J., Pietka, T. A., Liss, K. H. H., Thyfault, J. P., Patti, G. J., Finck, B. N., …, & Mukherjee, S. (2026). Adipose Tissue Overexpression of Nicotinamide Phosphoribosyltransferase Prevents Metabolic Dysfunction in Obese Mice via Extracellular Vesicles. Diabetes. https://doi.org/10.2337/db25-0914
Vancouver
Ferguson D, Gadson EI, Markan KR, Yoshino J, Palacios H, Lin M, et al. Adipose Tissue Overexpression of Nicotinamide Phosphoribosyltransferase Prevents Metabolic Dysfunction in Obese Mice via Extracellular Vesicles. Diabetes. 2026. doi:10.2337/db25-0914
BibTeX
@article{Ferguson2026,
author = {Ferguson, Daniel and Gadson, Elise I and Markan, Kathleen R and Yoshino, Jun and Palacios, Hector and Lin, Maxwell and Habibi, Mohammad and Tiash, Snigdha and Cui, Xiaoxia and Kouranova, Evguenia and Franczak, Edziu and Guo, Qiuyuan and Nguyen, Tan and Kealing, Jill and Pietka, Terri A and Liss, Kim H H and Thyfault, John P and Patti, Gary J and Finck, Brian N and Crewe, Clair and Mukherjee, Sandip},
title = {Adipose Tissue Overexpression of Nicotinamide Phosphoribosyltransferase Prevents Metabolic Dysfunction in Obese Mice via Extracellular Vesicles},
journal = {Diabetes},
year = {2026},
doi = {10.2337/db25-0914}
}
EUVIMED